Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism

[1]  W. Evans,et al.  Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. , 2009, Blood.

[2]  U. Kees,et al.  Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines. , 2009, Leukemia research.

[3]  Katrin Hoffmann,et al.  Prediction of relapse in paediatric pre‐B acute lymphoblastic leukaemia using a three‐gene risk index , 2008, British journal of haematology.

[4]  B. Schäfer,et al.  Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway. , 2007, Blood.

[5]  Richard S Larson,et al.  Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group. , 2007, Blood.

[6]  J. Downing,et al.  A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. , 2007, Blood.

[7]  Katrin Hoffmann,et al.  Identification of novel molecular prognostic markers for paediatric T‐cell acute lymphoblastic leukaemia , 2007, British journal of haematology.

[8]  F. Prósper,et al.  Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. , 2007, Blood.

[9]  Martin J Firth,et al.  In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblastic leukaemia , 2007, British journal of haematology.

[10]  Emma Saavedra,et al.  Energy metabolism in tumor cells , 2007, The FEBS journal.

[11]  H. Friess,et al.  Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors , 2007, Cancer biology & therapy.

[12]  M. Bauer,et al.  Spontaneous cell proliferation is associated with poor sensitivity to glucocorticoids in patients infected with HTLV , 2007, Cell proliferation.

[13]  Martin J Firth,et al.  Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines , 2006, British Journal of Cancer.

[14]  D. Durden,et al.  Role of Glutamine Depletion in Directing Tissue-specific Nutrient Stress Responses to L-Asparaginase* , 2006, Journal of Biological Chemistry.

[15]  K. Tachibana,et al.  Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors Bax and Bak. , 2006, Journal of the National Cancer Institute.

[16]  T. Golub,et al.  Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. , 2006, Cancer cell.

[17]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[18]  Martin J Firth,et al.  Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia , 2006, Leukemia.

[19]  S. Zunino,et al.  Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore. , 2006, Cancer letters.

[20]  R. Spang,et al.  Expression of Late Cell Cycle Genes and an Increased Proliferative Capacity Characterize Very Early Relapse of Childhood Acute Lymphoblastic Leukemia , 2006, Clinical Cancer Research.

[21]  George Davidson,et al.  Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. , 2006, Blood.

[22]  Nigel G J Richards,et al.  Asparagine synthetase chemotherapy. , 2006, Annual review of biochemistry.

[23]  C. Manetti,et al.  Metabolic profiling by 13C-NMR spectroscopy: [1,2-13C2]glucose reveals a heterogeneous metabolism in human leukemia T cells. , 2006, Biochimie.

[24]  R. Crazzolara,et al.  Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. , 2006, Blood.

[25]  Cheng Cheng,et al.  The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. , 2006, Blood.

[26]  A. Strasser,et al.  BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. , 2005, Blood.

[27]  P. Gaynon.  Childhood acute lymphoblastic leukaemia and relapse , 2005, British journal of haematology.

[28]  S. Armstrong,et al.  Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells. , 2005, Blood.

[29]  Martin J Firth,et al.  The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure , 2005, British journal of haematology.

[30]  A. Hall,et al.  Loss of heterozygosity and somatic mutations of the glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course. , 2005, Cancer research.

[31]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[32]  W. Tissing,et al.  Genetic Variations in the Glucocorticoid Receptor Gene Are Not Related to Glucocorticoid Resistance in Childhood Acute Lymphoblastic Leukemia , 2005, Clinical Cancer Research.

[33]  R. Pieters,et al.  Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. , 2005, European journal of cancer.

[34]  S. Percival,et al.  Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. , 2005, Cancer letters.

[35]  Cheng Cheng,et al.  Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. , 2004, The New England journal of medicine.

[36]  W. Zong,et al.  Alkylating DNA damage stimulates a regulated form of necrotic cell death. , 2004, Genes & development.

[37]  P. Hammerman,et al.  Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival , 2003, Molecular and Cellular Biology.

[38]  M. Ringnér,et al.  Gene expression profiles in a panel of childhood leukemia cell lines mirror critical features of the disease. , 2003, Molecular cancer therapeutics.

[39]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[40]  R. Kofler,et al.  The Cell Cycle Inhibitor p16INK4A Sensitizes Lymphoblastic Leukemia Cells to Apoptosis by Physiologic Glucocorticoid Levels* , 2001, The Journal of Biological Chemistry.

[41]  D. Bernhard,et al.  Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid‐induced apoptosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  A. Borkhardt,et al.  Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. , 1999, Blood.

[43]  M. D. Boer,et al.  Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants , 1998, Leukemia.

[44]  R. Pieters,et al.  In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. , 1995, Blood.

[45]  G. Melnykovych,et al.  Possible role of cholesterol in the susceptibility of a human acute lymphoblastic leukemia cell line to dexamethasone. , 1986, Cancer research.

[46]  J. Harmon,et al.  Glutamine synthetase induction by glucocorticoids in the glucocorticoid‐sensitive human leukemic cell line CEM‐C7 , 1982, Journal of cellular physiology.

[47]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[48]  Martin J Firth,et al.  Gene expression levels in small specimens from patients detected using oligonucleotide arrays , 2005, Molecular biotechnology.

[49]  R. Kofler,et al.  The cell cycle inhibitor p16(INK4A) sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levels. , 2001, The Journal of biological chemistry.

[50]  E. Cundari,et al.  Dexamethasone induces apoptosis in human T cell clones expressing low levels of Bcl-2 , 1999, Cell Death and Differentiation.

[51]  G. Melnykovych,et al.  The role of cholesterol in the glucocorticoid-mediated inhibition of cell cycle progression in human acute lymphoblastic leukemia cells. , 1987, Experimental cell research.

[52]  R. Herrmann,et al.  PER-117: a new human ALL cell line with an immature thymic phenotype. , 1987, Leukemia research.